Provided by Tiger Trade Technology Pte. Ltd.

Boise Cascade

82.47
+0.70000.86%
Post-market: 82.470.00000.00%19:30 EDT
Volume:261.15K
Turnover:21.51M
Market Cap:2.88B
PE:28.41
High:83.23
Open:82.05
Low:81.53
Close:81.77
52wk High:91.97
52wk Low:65.00
Shares:34.89M
Float Shares:34.34M
Volume Ratio:1.06
T/O Rate:0.76%
Dividend:0.88
Dividend Rate:1.07%
EPS(TTM):2.90
EPS(LYR):3.53
ROE:5.06%
ROA:2.86%
PB:1.42
PE(LYR):23.36

Loading ...

Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill

GlobeNewswire
·
Apr 27

Earning Preview: Boise Cascade this quarter’s revenue is expected to decrease by 3.71%, and institutional views are mostly bullish

Earnings Agent
·
Apr 27

Analysts Offer Insights on Materials Companies: Reliance Steel (RS) and Boise Cascade (BCC)

TIPRANKS
·
Apr 24

Press Release: Boise Cascade Company First Quarter 2026 Earnings Webcast and Conference Call

Dow Jones
·
Apr 22

Boise Cascade Is Maintained at Buy by Truist Securities

Dow Jones
·
Apr 15

Boise Cascade price target lowered to $100 from $103 at Truist

TIPRANKS
·
Apr 15

Goldman Sachs Remains a Hold on Boise Cascade (BCC)

TIPRANKS
·
Apr 10

Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the Upcoming 2026 Society for Investigative Dermatology Annual Meeting

GlobeNewswire
·
Apr 10

Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset

GlobeNewswire
·
Apr 01

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

GlobeNewswire
·
Mar 26

Press Release: Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering

Dow Jones
·
Mar 24

Boise Cascade Company publishes 2025 annual report

Reuters
·
Mar 21

Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025

GlobeNewswire
·
Mar 19

Boise Cascade Company announced its annual shareholders meeting via webcast

Reuters
·
Mar 18

D.A. Davidson Sticks to Its Buy Rating for Boise Cascade (BCC)

TIPRANKS
·
Mar 17

Michael Hayman elected chair of British Chambers of Commerce

cityam
·
Mar 16

Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset

GlobeNewswire
·
Mar 09

Removing UK’s tariff exemption could hurt small businesses, trade body warns

cityam
·
Mar 09

Medicus Pharma Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance and 40% Histological Clearance (CR) at Day 57 in 200μg Cohort

GlobeNewswire
·
Mar 05

Medicus Pharma To Participate in the 38th Annual Roth Conference

GlobeNewswire
·
Mar 03